- Home
- DOCN vs DYN Comparison
DOCN vs DYN Comparison
Compare DOCN & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCN | DYN |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.4B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DOCN | DYN |
|---|---|---|
| Price | $48.93 | $18.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $47.58 | $40.00 |
| AVG Volume (30 Days) | 1.5M | ★ 3.1M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 201.90 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $863,962,000.00 | N/A |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $18.85 | N/A |
| P/E Ratio | $18.24 | ★ N/A |
| Revenue Growth | ★ 14.20 | N/A |
| 52 Week Low | $25.45 | $6.36 |
| 52 Week High | $52.20 | $26.22 |
Technical Indicators
Market Signals| Indicator | DOCN | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 42.04 |
| Support Level | $47.85 | $18.92 |
| Resistance Level | $51.90 | $21.00 |
| Average True Range (ATR) | 1.74 | 0.94 |
| MACD | -0.03 | -0.15 |
| Stochastic Oscillator | 83.54 | 8.27 |
Price Performance
Historical ComparisonAbout DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.